Fecal Microbiota Transplantation & Inflammatory bowel disease
Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.
Protocol for Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Fecal Microbiota Transplantation for the Treatment of Inflammatory Bowel Disease: An Update.
Autologous fecal microbiota transplantation for the treatment of inflammatory bowel disease.
Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome.
The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease.
Fecal transplantation for treatment of inflammatory bowel disease.
Fecal microbiota transplantation in inflammatory bowel disease patients: A systematic review and meta-analysis.
Insights into the role of fecal microbiota transplantation for the treatment of inflammatory bowel disease.
Toll-like Receptors and Inflammatory Bowel Disease.
The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis.
Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease.
Mesenchymal stem cell-gut microbiota interaction in the repair of inflammatory bowel disease: an enhanced therapeutic effect.
Immunological mechanisms underpinning faecal microbiota transplantation for the treatment of inflammatory bowel disease.
Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases.
The microbiota in inflammatory bowel disease: current and therapeutic insights.
New treatment options for inflammatory bowel diseases.
Perspectives on Current and Novel Treatments for Inflammatory Bowel Disease.
Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.
Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.
Treating children with inflammatory bowel disease: Current and new perspectives.
Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates.
Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease - An Overview of Human Studies.
Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease.
The Microbiome in Visceral Medicine: Inflammatory Bowel Disease, Obesity and Beyond.
Recipe for IBD: can we use food to control inflammatory bowel disease?
Secondary causes of inflammatory bowel diseases.
Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.
The potential therapeutic role of Lactobacillus reuteri for treatment of inflammatory bowel disease.
Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.
Low FODMAP Diet for Functional Gastrointestinal Symptoms in Quiescent Inflammatory Bowel Disease: A Systematic Review of Randomized Controlled Trials.
Spp24 is associated with endocytic signalling, lipid metabolism, and discrimination of tissue integrity for 'leaky-gut' in inflammatory bowel disease.